Specifically, TMAO induces tumor cell pyroptosis by activating the endoplasmic reticulum stress kinase PERK, thereby enhancing CD8+ T-cell-mediated antitumor immunity in TNBC in vivo (113). Here, CD8A is linked to neoplasm.